about
On the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug MonitoringCurrent and future use of point-of-care tests in primary care: an international survey in Australia, Belgium, The Netherlands, the UK and the USAPoint-of-care diagnostics for niche applications.Bedside ABG, electrolytes, lactate and procalcitonin in emergency pediatrics.Existing and Emerging Technologies for Point-of-Care Testing.Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa.Diagnostic accuracy of point-of-care tests for hepatitis C virus infection: a systematic review and meta-analysisApplication of flat panel OLED display technology for the point-of-care detection of circulating cancer biomarkersAccuracy of Rapid Point-of-Care Diagnostic Tests for Hepatitis B Surface Antigen-A Systematic Review and Meta-analysis.The cost-utility of point-of-care troponin testing to diagnose acute coronary syndrome in primary care.Clinical evaluation of whole blood prothrombin time (PT) and international normalized ratio (INR) using a Laser Speckle Rheology sensorEvidence-based laboratory medicine.Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature.Point-of-care diagnostics to improve maternal and neonatal health in low-resource settings.Point-of-care urine culture for managing urinary tract infection in primary care: a randomised controlled trial of clinical and cost-effectiveness.Economic evaluation of point-of-care testing in the remote primary health care setting of Australia's Northern Territory.Will the current National Strategic Plan enable South Africa to end AIDS, Tuberculosis and Sexually Transmitted Infections by 2022?
P2860
Q27024074-2F31AB36-18DE-4A7F-8A00-5E93B82A7D60Q29041707-A90BC0FE-41ED-4C6F-B68D-0226F91C19EDQ30357499-CE4C26D9-5028-4353-9DD0-C3D9FDBAA213Q34357323-FF946065-B0E5-46F4-A81D-4A9F3173910EQ34376474-4D4B95A6-709C-46A6-BF0B-DF75AEC709C4Q34724571-F6640FB9-81AD-41FD-ACA3-4E1DECF19C6FQ35224772-EF8C645B-22BD-48AE-B5EF-63C028EF468BQ37061534-D352065F-B8D8-4609-864F-71A16BF7D7D1Q38371565-FCDB2503-5392-4039-AF0D-461621CC602CQ38647973-DF4EFE4F-7933-491C-92F3-15EE4239D330Q41504206-37B4CE09-4700-4F8A-8592-3A0B7CC89267Q41874611-1BBFB118-E444-416B-8945-CE899E475C4FQ45191773-EDD8D550-5B6B-4436-B0E2-3D9B5FECD9DCQ46303043-CC72AFF3-5CD0-4212-990C-EA3CF5E4E7BAQ53706408-2D8D508E-5E09-4888-BE27-8715BC627514Q55408079-51611EF8-6F33-42E0-8A73-DCADBFCE5CBFQ57818182-744F5C16-01C1-4A5C-9A29-6F91763765FA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Economic Evidence and Point-of-Care Testing.
@en
Economic Evidence and Point-of-Care Testing.
@nl
type
label
Economic Evidence and Point-of-Care Testing.
@en
Economic Evidence and Point-of-Care Testing.
@nl
prefLabel
Economic Evidence and Point-of-Care Testing.
@en
Economic Evidence and Point-of-Care Testing.
@nl
P2860
P1476
Economic Evidence and Point-of-Care Testing.
@en
P2093
Andrew St John
Christopher P Price
P2860
P577
2013-08-01T00:00:00Z